Mars Inc., the confectionery, pet care, and food giant, has licensed Pairwise’s gene editing platform, called Fulcrum, to ...

Hatteras was founded in 2000 with the closing of Hatteras Venture Partners I, a seed-stage venture fund with $2.93 million in capital. Today, the firm is focused on seed- and early stage companies in ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

The NC Biopharma Networking Group will host a networking event on August 19. Whether you are new to networking or a seasoned veteran, this is a great opportunity to make valuable connections within ...

Final plans are taking shape for Wilson Community College’s Biomanufacturing Education and Skills Training (BEST) Center of Eastern North Carolina. The College recently revealed architectural ...

Hosted by the Small Business and Technology Development Center, this full-day event will guide North Carolina innovators and entrepreneurs through the complex world of funding. From federal R&D grants ...

Coriolis Pharma, a German contract research, development and manufacturing organization, announced plans to invest $10.8 million and add 50 new jobs over the next five years in Morrisville. The ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Among the many obstacles between idea and market in life sciences and biotechnology product development, the main challenge is securing capital. NCBiotech offers several business funding programs that ...

Many of the latest breakthroughs in helping the human body heal itself can be found in downtown Winston-Salem. That’s where the Wake Forest Institute for Regenerative Medicine, as well as a partner ...